Drug Profile
Research programme: Japanese encephalitis vaccine - ADImmune
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator ADImmune Corporation
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Encephalitis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Encephalitis in Taiwan (Injection)
- 11 Oct 2006 Preclinical trials in Encephalitis in Taiwan (Injection)